The Massachusetts Supreme Judicial Court ruled that Merck may be held liable for injuries caused by inadequate labeling for generics of its products. Source: Drug Industry Daily
President Trump said that his administration will cut nationwide opioid prescriptions by one third over the next three years and increase funding for non-addictive painkiller development. Source: Drug Industry Daily
Alzheon hopes to raise about $80 million, which will help fund two Phase III clinical trials for its ALZ-801 for Alzheimer’s disease. Source: BioSpace
Heron Therapeutics said its late-stage anesthetic used to treat bunionectomy and hernia repair hit all primary and key secondary endpoints in two Phase III trials that cut down on the…
Denali Therapeutics, located in South San Francisco, California, had a lot of news to share today. Source: BioSpace
Companies that have a strong focus on developing drugs that target messenger RNA (mRNA) may be ahead of the curve when it comes to potentially tapping into a lucrative market…
Cidara Therapeutics reported its mid-stage antifungal candidate hit its primary endpoints and is on track to begin Phase III testing later this year. Source: BioSpace
In the world of politics and civil rights, the ideas of gender and transgender have been a hot-button issue. But a new study suggests that transgender people may have a…
Here are six biotech companies that should benefit the most from research-and-development spending trends that are expected to stimulate biotech development. Source: BioSpace
The FDA served Terra Biological a warning letter for marketing a misbranded, unapproved new drug product on its website. Source: Drug Industry Daily